0.2SEK
10.01 MSEK
89.21 MSEK
22.18 M
About SYNTHETICMR AB
Sector
Industry
CEO
Ulrik Harrysson
Website
Headquarters
Linköping
Employees (FY)
37
Founded
2007
ISIN
SE0015987946
FIGI
BBG005F21BP4
SyntheticMR AB engages in the development and marketing of software solutions for magnetic resonance imaging. The firm offers products under the brand SyMRI. Its products include SyMRI NEURO and SyMRI MSK. The company was founded by Jan Bertus Marten Warntjes on February 16, 2007 and is headquartered in Linköping, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SYNT is 28.4 SEK — it has decreased by 0.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange SYNTHETICMR AB stocks are traded under the ticker SYNT.
SYNTHETICMR AB is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
SYNT stock is 3.64% volatile and has beta coefficient of 0.45. Check out the list of the most volatile stocks — is SYNTHETICMR AB there?
SYNT earnings for the last quarter are 0.10 SEK per share, whereas the estimation was 0.10 SEK resulting in a −4.41% surprise. The estimated earnings for the next quarter are 0.22 SEK per share. See more details about SYNTHETICMR AB earnings.
SYNTHETICMR AB revenue for the last quarter amounts to 21.85 M SEK despite the estimated figure of 21.71 M SEK. In the next quarter revenue is expected to reach 30.63 M SEK.
Yes, you can track SYNTHETICMR AB financials in yearly and quarterly reports right on TradingView.
SYNT stock has fallen by 8.97% compared to the previous week, the month change is a 16.87% rise, over the last year SYNTHETICMR AB has showed a 11.80% decrease.
SYNT net income for the last quarter is 4.58 M SEK, while the quarter before that showed 4.09 M SEK of net income which accounts for 12.17% change. Track more SYNTHETICMR AB financial stats to get the full picture.
Today SYNTHETICMR AB has the market capitalization of 1.19 B, it has decreased by 2.35% over the last week.
Like other stocks, SYNT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYNTHETICMR AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 37.00 employees. See our rating of the largest employees — is SYNTHETICMR AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYNTHETICMR AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYNTHETICMR AB stock shows the neutral signal. See more of SYNTHETICMR AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SYNTHETICMR AB future price: according to them, SYNT price has a max estimate of 30.00 SEK and a min estimate of 30.00 SEK. Read a more detailed SYNTHETICMR AB forecast: see what analysts think of SYNTHETICMR AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYNTHETICMR AB EBITDA is 21.23 M SEK, and current EBITDA margin is 18.34%. See more stats in SYNTHETICMR AB financial statements.